Print Friendly, PDF & Email

Expanding the Reach of Molecular Imaging

By providing cutting-edge research applications and complete infrastructure solutions, GE helps industry understand disease from the beginning.

As the world better understands molecular medicine, there is a growing convergence of therapeutics and diagnostics in the healthcare industry. Jean Luc Vanderheyden, Molecular Imaging Global Leader at GE Healthcare, explains how the company is at the forefront of this convergence with the latest in radiopharmacy and pre-clinical innovations.